We are live on
!
Find out more
Pacific Biosciences
PACB
PACB
150 hedge funds and large institutions have $756M invested in Pacific Biosciences in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 67 increasing their positions, 40 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
68% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 40
1.72% more ownership
Funds ownership: 79.95% → 81.67% (+1.7%)
2% less call options, than puts
Call options by funds: $1.2M | Put options by funds: $1.22M
6% less funds holding
Funds holding: 160 → 150 (-10)
13% less capital invested
Capital invested by funds: $873M → $756M (-$116M)
24% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 25
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
150
Holders Change
-10
Holders Change %
-6.25%
% of All Funds
3.26%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
19
Increased
67
Reduced
40
Closed
25
Calls
$1.2M
Puts
$1.22M
Net Calls
-$20K
Net Calls Change
+$3.15M
Top Buyers
| 1 |
WIC
Water Island Capital
New York
|
+$29M |
| 2 |
Goldman Sachs
New York
|
+$17.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$12.4M |
| 4 |
VI
Versor Investments
New York
|
+$8.87M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$7.34M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$14.6M |
| 2 |
Citigroup
New York
|
-$14M |
| 3 |
BHMP
Bardin Hill Management Partners
New York
|
-$11.8M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$8.98M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.12M |
